# Oramed Pharmaceuticals Inc.: Form 8-K, filed Feb 20, 2026

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2026-02-20
- Accepted by EDGAR: Feb 20, 2026, 21:26 ET
- Period: 2026-02-19
- Accession: 0001012975-26-000195
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/ormp-20260219.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/ormp-20260219.htm

Filed Feb 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001012975-26-000195. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.